In the latest D2C news India and D2C daily news, brain health startup Ivory has raised $1 million in a seed funding round led by Draper Associates, SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI, marking another strong signal of investor confidence in India’s rapidly evolving direct-to-consumer India healthcare space. As one of the latest D2C startups in the healthtech segment, Ivory is building a differentiated, science-backed platform focused on cognitive health, an area that remains largely underserved in the broader D2C ecosystem India.
This round adds to Ivory’s growing momentum in D2C funding news, following its earlier $1 million raise co-led by IIM-A Ventures and Capital A, along with an additional $500K from Capital A in early 2024. The consistent capital inflow highlights strong D2C investor insights and positions Ivory among emerging VC-backed D2C brands addressing preventive healthcare through technology and personalization.
Founded in early 2023 by Issac John and Rahul Krishnan, the Mumbai-based startup is focused on early detection and proactive cognitive care. Ivory’s D2C business model India leverages neuroscience, neuropsychology, and data-driven interventions to offer clinical-grade cognitive assessments directly to consumers through its app. This reflects a growing shift in D2C consumer behavior India, where users are increasingly prioritizing preventive and personalized healthcare solutions.
The fresh capital will be used to strengthen Ivory’s technology stack, expand clinical capabilities, and enhance its product offerings, aligning with broader D2C expansion plans seen across the healthtech ecosystem. By focusing on scalable, evidence-based solutions, Ivory is contributing to D2C supply chain innovation in digital healthcare, ensuring that high-quality cognitive care becomes more accessible and trackable.
What makes Ivory stand out in the D2C industry news landscape is its integrated approach. The platform combines clinical expertise with digital accessibility, supported by a multidisciplinary team spanning neuroscience, neurology, general medicine, and neuropsychology. Its recent partnership with Metropolis Healthcare to launch the TruHealth Mind & Body package further strengthens its position, blending diagnostics with cognitive assessments—an example of evolving omnichannel D2C strategy in healthcare.
From a D2C market trends 2025 perspective, the rise of D2C wellness startups focused on mental and cognitive health is becoming increasingly prominent. Ivory is tapping into this opportunity by addressing a critical gap—making cognitive screening a part of routine preventive care rather than a reactive process. This aligns with global benchmarks while positioning the company strongly within India’s D2C market news and insights narrative.
While Ivory competes with global platforms like Cogstate, Altoida, Pearson, BrainCheck, and Linus Health, as well as traditional assessment tools such as MoCA and MMSE, its digital-first, user-friendly approach gives it a competitive edge. The platform’s ability to combine clinical accuracy with everyday usability reflects strong D2C brand building stories and a scalable D2C go-to-market strategy.
As part of what’s happening in India’s D2C space today, Ivory represents the next wave of D2C startups—where healthcare meets technology, personalization, and accessibility. With strong funding, a clear vision, and a growing ecosystem of partnerships, Ivory is well-positioned to scale rapidly and emerge as a key player in India’s D2C wellness and healthtech ecosystem.
